Evidence map›Paper›PMID 34985730›Full record

ReviewJournal of physiology and biochemistry2022

Benefits, mechanisms, and risks of intermittent fasting in metabolic syndrome and type 2 diabetes.

Lisandra Joaquim, Ana Faria, Helena Loureiro, Paulo Matafome

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of physiology and biochemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lisandra JoaquimInstituto Politécnico de Coimbra, Coimbra Health School (ESTeSC), Coimbra, Portugal.
Ana FariaInstituto Politécnico de Coimbra, Coimbra Health School (ESTeSC), Coimbra, Portugal.
Helena LoureiroInstituto Politécnico de Coimbra, Coimbra Health School (ESTeSC), Coimbra, Portugal.
Paulo MatafomeInstituto Politécnico de Coimbra, Coimbra Health School (ESTeSC), Coimbra, Portugal. paulo.matafome@uc.pt.ORCID http://orcid.org/0000-0002-3422-290X
Polytechnic Institute of Coimbra · PT

Funding

Fundação para a Ciência e a Tecnologia Strategic Project UIDB/04539/2020 (CIBB)
6 · The paper itself

Abstract

One of the emergent nutritional strategies for improving multiple features of cardiometabolic diseases is the practice of intermittent fasting (IF), which consists of alternating periods of eating and fasting. IF can reduce circulating glucose and insulin levels, fat mass, and the risk of developing age-related pathologies. IF appears to upregulate evolution-conserved adaptive cellular responses, such as stress-response pathways, autophagy, and mitochondrial function. IF was also observed to modulate the circadian rhythms of hormones like insulin or leptin, among others, which levels change in conditions of food abundance and deficit. However, some contradictory results regarding the duration of the interventions and the anterior metabolic status of the participants suggest that more and longer studies are needed in order to draw conclusions. This review summarizes the current knowledge regarding the role of IF in the modulation of mechanisms involved in type 2 diabetes, as well as the risks.

Indexed as

Diabetes Mellitus, Type 2Metabolic SyndromeFastingHumansInsulinObesityInsulinDiabetesGlucoseInsulin resistanceIntermittent fasting

Identifiers

PMID34985730
OpenAlexW4206070393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.